Physician profile
Peter D Emanuel
NPI 1205844594
$52,769.59
in general payments reported to CMS, 2019-2025
71 companies · $3,751 in 2025
The $3,751 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,519 · 2021: $6,735 · 2022: $3,295 · 2023: $3,708 · 2024: $3,553 · 2025: $3,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $25.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,986.24 |
| Education | $25.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $30,011.94 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Janssen Scientific Affairs, LLC | $2,900.35 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $2,592.17 | 2019-2025 | Imfinzi, Enhertu, Tagrisso |
| Novartis Pharmaceuticals Corporation | $1,483.93 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,178.25 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Adaptive Biotechnologies Corporation | $1,050.29 | 2020-2022 | |
| Janssen Biotech, INC. | $912.49 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Pfizer INC. | $838.99 | 2019-2025 | |
| Incyte Corporation | $803.28 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Lilly USA, LLC | $608.30 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $597.80 | 2020-2023 | Adcetris, Tukysa |
| Beigene USA, INC. | $549.15 | 2020-2025 | Brukinsa |
| Exelixis INC. | $503.83 | 2021-2025 | Cabometyx |
| Genentech USA, INC. | $500.80 | 2019-2025 | Lunsumio, Tecentriq, Polivy |
| Genzyme Corporation | $471.24 | 2019-2025 |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $458.44 | 2019-2025 | Opdivo, Onureg, Opdualag |
| Abbvie INC. | $450.58 | 2021-2025 | |
| Amgen INC. | $445.56 | 2019-2023 | Lumakras, Kyprolis, Xgeva |
| Astellas Pharma US INC | $423.27 | 2019-2025 | Padcev, Xospata, Xtandi |
| Daiichi Sankyo INC. | $376.26 | 2019-2025 | Enhertu, Datroway |
| Emd Serono, INC. | $373.12 | 2020-2025 | Bavencio |
| Alnylam Pharmaceuticals INC. | $344.22 | 2020-2025 | Givlaari |
| Eisai INC. | $317.45 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $313.65 | 2019-2023 | Imbruvica, Epkinly |
| Ipsen Biopharmaceuticals, INC | $259.46 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Regeneron Healthcare Solutions, INC. | $232.64 | 2021-2024 | Libtayo |
| Aveo Pharmaceuticals, INC. | $205.30 | 2022-2025 | Fotivda |
| Pharmaessentia USA Corporation | $201.62 | 2022-2025 | Besremi |
| Gilead Sciences, INC. | $200.67 | 2022-2025 | Trodelvy |
| Array Biopharma INC | $189.08 | 2022-2025 | Lorbrena, Braftovi, Mektovi |
| Sobi, INC | $177.27 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.82 | 2020-2025 | |
| Glaxosmithkline, LLC. | $162.99 | 2023-2025 | Jemperli, Zejula, Ojjaara |
| Kite Pharma, INC. | $144.49 | 2020-2023 | Yescarta |
| Pharmacosmos Therapeutics INC. | $143.22 | 2023-2025 | Monoferric, Cosela |
| Karyopharm Therapeutics INC. | $136.51 | 2020-2023 | Xpovio |
| Puma Biotechnology, INC. | $135.12 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $132.55 | 2021-2024 | Tavalisse, Rezlidhia |
| Geron Corporation | $124.33 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $112.61 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.32 | 2021-2025 | Ninlaro, Iclusig |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.03 | 2023-2025 | Gilotrif |
| Kyowa Kirin, INC. | $95.18 | 2019-2021 | |
| Epizyme, INC. | $88.23 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $85.95 | 2022 | |
| Genentech, INC. | $82.93 | 2024 | Venclexta, Lunsumio |
| Adc Therapeutics America, INC. | $72.23 | 2023-2024 | |
| Morphosys, US INC. | $69.89 | 2023 | Monjuvi |
| Mirati Therapeutics, INC. | $67.29 | 2023-2024 | Krazati |
| Recordati_rare_diseases_inc. | $64.04 | 2024-2025 | Sylvant, Enjaymo |
| Janssen Pharmaceuticals, INC | $59.72 | 2019-2024 | |
| G1 Therapeutics, INC. | $58.35 | 2022-2023 | Cosela |
| Beone Medicines USA, INC. | $58.22 | 2025 | Brukinsa |
| Amag Pharmaceuticals, INC. | $53.37 | 2021-2022 | |
| Viiv Healthcare Company | $51.11 | 2025 | Dovato |
| Alexion Pharmaceuticals, INC. | $49.35 | 2020-2025 | Ultomiris |
| Blueprint Medicines Corporation | $42.86 | 2024-2025 | Ayvakit |
| Stemline Therapeutics INC. | $41.88 | 2023-2024 | Orserdu |
| Agios Pharmaceuticals, INC. | $41.45 | 2019-2025 | Pyrukynd |
| Acceleron Pharma, INC. | $35.41 | 2021 | |
| Intercept Pharmaceuticals, INC. | $27.61 | 2019 | |
| Fresenius Kabi USA, LLC | $27.18 | 2025 | Stimufend |
| Abbott Laboratories | $24.50 | 2025 | Portico |
| Foundation Medicine, INC. | $21.89 | 2019 | |
| Menarini Silicon Biosystems, INC. | $20.33 | 2024 | |
| Emmaus Medical, INC. | $19.82 | 2023 | Endari |
| Jazz Pharmaceuticals INC. | $17.67 | 2019 | |
| Caris Mpi, INC. | $16.13 | 2025 | Mi Cancer Seek |
| Acrotech Biopharma INC. | $15.40 | 2025 | Beleodaq |
| Tersera Therapeutics LLC | $15.36 | 2024 | Zoladex |
| Deciphera Pharmaceuticals INC. | $13.85 | 2025 | Qinlock, Romvimza |
Drugs and devices associated with these payments
Keytruda $507Enhertu $500Reblozyl $484Cabometyx $388Imfinzi $328Venclexta $308Brukinsa $300Jakafi $293Lynparza $289Imbruvica $282Monjuvi $278Lenvima $278Sarclisa $276Tukysa $264Scemblix $259Ibrance $255Padcev $211Adcetris $210Pluvicto $205Lunsumio $203Kisqali $194Darzalex $189Libtayo $182Besremi $176Fabhalta $174Fotivda $167Onivyde $163Lorbrena $151Givlaari $148Opdivo $142Braftovi $138Mektovi $135Jaypirca $133Trodelvy $127Talvey $125Tecvayli $125Rytelo $124Xospata $123Elahere $121Epkinly $115Vonjo $114Tecentriq $113Monoferric $113Polivy $111Elrexfio $111Oxbryta $109Tasigna $104Tibsovo $99.09Xtandi $97.62Bosulif $94.35Verzenio $93.60Opdualag $92.68Vitrakvi $89.67Stivarga $89.67Zejula $85.84Jemperli $85.84Gilotrif $80.45Nerlynx $79.11Onureg $78.52Retevmo $77.23Lutathera $74.11Lumakras $67.69Ayvakit $67.47Krazati $67.29Welireg $64.86Ojjaara $63.99Doptelet $63.31Orgovyx $59.62Promacta $57.32Rybrevant $57.10Inlyta $56.60Nubeqa $54.02Piqray $53.10Xalkori $52.70Dovato $51.11Somatuline Depot $48.79Tagrisso $48.48Alecensa $46.53Cosela $46.08Bavencio $43.48Erleada $42.03Akeega $42.03Balversa $42.03Orserdu $41.88Mekinist $40.26Kyprolis $38.91Talzenna $34.61Pomalyst $34.28Sylvant $34.01Ultomiris $33.79Xofigo $33.55Xpovio $31.52Comirnaty $30.17Enjaymo $30.03Phesgo $27.58Stimufend $27.18Datroway $26.88Elitek $25.23Portico $24.50Vectibix $24.27
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Emanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.